Study title: Uchida Y et al. Phase II study of NY-198 ophthalmic solution in multicenter double-blind design; Phase II study of NY-198 ophthalmic solution. No report date. Amendment to clinical trial report by Dr. A. Jauch, January 4, 1994, + Appendix 1 and 2.Uchida Y et al. Phase II study of NY-198 ophthalmic solution in multicenter double-blind design; Phase II study of NY-198 ophthalmic solution. No report date. Amendment to clinical trial report by Dr. A. Jauch, January 4, 1994, + Appendix 1 and 2.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Eye Diseases [C11] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: LOMEFLOXACIN | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |